Pediatric Differentiated Thyroid Carcinoma of Follicular Cell Origin: Prognostic Significance of Histologic Subtypes.

BACKGROUND Thyroid cancers are rare in the pediatric age group, and unlike in adults, few data are available regarding the clinical implication of histologic subtypes in the pediatric population. The purpose of the current study was to determine the prognostic significance of histologic subtypes of differentiated thyroid cancer (DTC) in a large series of children and adolescents followed at a single institution. METHODS A retrospective review was conducted of all pediatric DTC patients who were treated and followed between 1988 and 2012. Sixty-two patients (median age at diagnosis 13.8 years, median age at follow-up 18 years, 77% female) were assessed. The most common subtypes included classic papillary thyroid carcinoma (PTC; 48%), diffuse sclerosing PTC (16%), and follicular variant PTC (15%); 37% were considered "high-risk" histologies based on adult criteria. RESULTS In a multivariate model, only extensive extrathyroidal extension (ETE), defined as the presence of two or more microscopic foci of tumor cells ≤1 mm in size each or any foci >1 mm in size invading beyond the thyroid capsule into perithyroid soft tissue or organs, was significantly associated with extent of disease at presentation. At last follow-up, 76% of subjects had no evidence of disease, 18% had persistent disease, and 5% had recurrent/progressive disease. Event-free survival was associated with extent of disease at presentation (p = 0.01), extensive ETE at diagnosis (p < 0.01), and male sex (p = 0.01), but not histologic subtype (p = 0.20). CONCLUSIONS Pediatric DTC carries an excellent prognosis. Extensive ETE at diagnosis was found to be an independent predictor of extent of disease at presentation, as well as event-free survival. Unlike in the adult population, "high-risk" histologic subtypes did not independently predict extent of disease at presentation or event-free survival in this pediatric population with DTC.

[1]  M. Santoro,et al.  BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas. , 2004, The Journal of clinical endocrinology and metabolism.

[2]  C. Sklar,et al.  Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group. , 2000, Journal of pediatric surgery.

[3]  S. Rivkees,et al.  The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy. , 2011, Endocrine reviews.

[4]  R. Valcavi,et al.  Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. , 2009, Thyroid : official journal of the American Thyroid Association.

[5]  B. Jarzab,et al.  Total Thyroidectomy and Adjuvant Radioiodine Treatment Independently Decrease Locoregional Recurrence Risk in Childhood and Adolescent Differentiated Thyroid Cancer , 2007, Journal of Nuclear Medicine.

[6]  M. Phillip,et al.  Differentiated thyroid carcinoma in pediatric patients: comparison of presentation and course between pre-pubertal children and adolescents. , 2009, The Journal of pediatrics.

[7]  J. Hamilton,et al.  Thyroid cancer in childhood: a retrospective review of childhood course. , 2010, Thyroid : official journal of the American Thyroid Association.

[8]  C. Rodríguez-Galindo,et al.  Increase in the incidence of differentiated thyroid carcinoma in children, adolescents, and young adults: a population-based study. , 2014, The Journal of pediatrics.

[9]  RiveraMichael,et al.  Prognostic implications of papillary thyroid carcinoma with tall-cell features. , 2014 .

[10]  R. Owen,et al.  Aggressive variants of papillary thyroid carcinoma , 2011, Head & neck.

[11]  R. Hruban,et al.  Follicular variant of papillary thyroid carcinoma. A clinicopathologic study , 1994, Cancer.

[12]  S. Rivkees,et al.  Differentiated thyroid cancer in children: diagnosis and management , 2008, Current opinion in oncology.

[13]  Stephanie L. Lee,et al.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[14]  J. Chan,et al.  Diffuse sclerosing variant of papillary thyroid carcinoma--clinical features and outcome. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[15]  A. Varan,et al.  Thyroid Cancer in Pediatric Age Group: An Institutional Experience and Review of the Literature , 2013, Journal of pediatric hematology/oncology.

[16]  A. Ferrari,et al.  Papillary Carcinoma of the Thyroid Gland of Childhood and Adolescence: Morphologic Subtypes, Biologic Behavior and Prognosis: A Clinicopathologic Study of 42 Sporadic Cases Treated at a Single Institution During a 30-Year Period , 2006, The American journal of surgical pathology.

[17]  Michael R. Tuttle,et al.  Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults , 1998, Clinical endocrinology.

[18]  C. Sklar,et al.  Differentiated thyroid cancer: determinants of disease progression in patients <21 years of age at diagnosis: a report from the Surgical Discipline Committee of the Children's Cancer Group. , 1998, Annals of surgery.

[19]  L. Koniaris,et al.  Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients. , 2009, The Journal of surgical research.

[20]  L. Holmes,et al.  Pediatric Thyroid Carcinoma Incidence and Temporal Trends in the USA (1973–2007): Race or Shifting Diagnostic Paradigm? , 2012, ISRN oncology.

[21]  J. Shah,et al.  Poorly differentiated thyroid carcinoma presenting with gross extrathyroidal extension: 1986-2009 Memorial Sloan-Kettering Cancer Center experience. , 2013, Thyroid : official journal of the American Thyroid Association.

[22]  P. Grigsby,et al.  Childhood and adolescent thyroid carcinoma , 2002, Cancer.

[23]  R. Tuttle,et al.  Serum thyrotropin (TSH) levels after recombinant human TSH injections in children and teenagers with papillary thyroid cancer. , 2005, The Journal of clinical endocrinology and metabolism.

[24]  S. Waguespack,et al.  Initial management and follow-up of differentiated thyroid cancer in children. , 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

[25]  J. Shah,et al.  Prognostic implications of papillary thyroid carcinoma with tall-cell features. , 2014, Thyroid : official journal of the American Thyroid Association.

[26]  B. Jarzab,et al.  Differentiated thyroid cancer in children and adults: same or distinct disease? , 2007, Hormones.

[27]  M. Charron,et al.  Evidence-based Review of Treatment and Follow up of Pediatric Patients with Differentiated Thyroid Carcinoma , 2006, Journal of pediatric endocrinology & metabolism : JPEM.

[28]  M. Reinalda,et al.  Long-Term Outcome in 215 Children and Adolescents with Papillary Thyroid Cancer Treated During 1940 Through 2008 , 2010, World Journal of Surgery.

[29]  F. Pacini Thyroid cancer in children and adolescents , 2002, Journal of endocrinological investigation.

[30]  R. Tuttle,et al.  The ret/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults. , 2000, The Journal of clinical endocrinology and metabolism.

[31]  D. Robie,et al.  Tumor Size and Extent of Disease at Diagnosis Predict the Response to Initial Therapy for Papillary Thyroid Carcinoma in Children and Adolescents , 2003, Journal of pediatric endocrinology & metabolism : JPEM.

[32]  Yeh Sd,et al.  131I therapy for pediatric thyroid cancer. , 1997 .

[33]  P. Delaere,et al.  Thyroid cancer in children and adolescents , 2013, Current opinion in otolaryngology & head and neck surgery.

[34]  R. Vigneri,et al.  A diffuse sclerosing variant of papillary thyroid carcinoma: clinical and pathologic features and outcomes of 34 consecutive cases. , 2011, Thyroid : official journal of the American Thyroid Association.